Trials / Active Not Recruiting
Active Not RecruitingNCT06680531
A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Primary Objective： 1\) To evaluate the pharmacodynamic interaction between YZJ-1139 tablets and Escitalopram oxalate tablets in healthy subjects; 2) To evaluate the pharmacokinetic interaction between YZJ-1139 tablets and Escitalopram oxalate tablets in healthy subjects; To observe the safety of YZJ-1139 tablets taken together with Escitalopram oxalate tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YZJ-1139 tablets | YZJ-1139 tablets are administered orally single dose |
| DRUG | Escitalopram oxalate tablets | •oral tablet, QD |
| DRUG | YZJ-1139 simulated tablets | oral tablet, QD |
Timeline
- Start date
- 2024-08-31
- Primary completion
- 2024-09-18
- Completion
- 2025-01-01
- First posted
- 2024-11-08
- Last updated
- 2024-11-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06680531. Inclusion in this directory is not an endorsement.